Quest Diagnostics has seen its Fair Value Estimate rise slightly, climbing from $188.19 to $191.56 per share as analysts factor in updated growth expectations. This change is supported by increased ...

MakeMyTrip has announced it will report its fiscal 2026 second quarter results on October 28, 2025, with earnings per share estimated at US$0.45 and revenue expected to rise by over 25% year-over-year ...